Endpoints News Mar 3, 2026 FDA explains how some copycat drugs can still win three years of exclusivity
Agilent Mar 3, 2026 Morgan Stanley Lowers Agilent Technologies (NYSE:A) Price Target to $160.00 - MarketBeat
10x Genomics Blog Mar 3, 2026 Commit To Buy 10x Genomics At $15, Earn 20.6% Annualized Using Options - Nasdaq
Endpoints News Mar 3, 2026 EveryOne Medicines shuts down, ending custom cure venture that banked on new FDA pathway
FierceBiotech Mar 3, 2026 MindMaze seeks 'strategic alternatives,' eyes US expansion as 2 board members exit
FierceBiotech Mar 3, 2026 Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug
Thermo Fisher Mar 3, 2026 Thermo Fisher at Raymond James Conference: Strategic Growth Insights - Investing.com